Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-17

FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Original Application (Lifestar Pharma LLC)

View source ↗

Summary

The FDA approved a generic combination tablet of olmesartan medoxomil and hydrochlorothiazide for hypertension. The applicant is Lifestar Pharma LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olmesartan Medoxomil and Hydrochlorothiazide (olmesartan medoxomil; hydrochlorothiazide)

Snippet

ORIG AP for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE)